financetom
Business
financetom
/
Business
/
TotalEnergies Inks Another Eagle Ford Basin Deal, Exec Says Stake Purchase 'Strengthens Upstream Gas Position'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TotalEnergies Inks Another Eagle Ford Basin Deal, Exec Says Stake Purchase 'Strengthens Upstream Gas Position'
Oct 2, 2024 11:59 PM

TotalEnergies SE ( TTE ) shares are trading higher premarket Friday. The company reached an agreement with Lewis Energy Group to acquire a 45% stake in its dry gas-producing assets in Texas’ Eagle Ford basin for an undisclosed amount.

Terms of the deal were not disclosed.

The acquisition of low-cost, long-life assets enhances TotalEnergies’ presence in the U.S. gas value chain and follows the company’s Texas Dorado acquisition in April 2024.

This marks TotalEnergies’ second acquisition of non-operated shale gas assets in 2024, following the purchase of a non-operated interest in the Dorado asset, also in the Eagle Ford basin.

Additionally, TotalEnergies operates approximately 500 Mcf/d of technical production in the Barnett region.

"This acquisition further strengthens our upstream gas position in the United States and contributes to our integrated LNG position with a low cost upstream gas supply", said TotalEnergies President Nicolas Terraz.

This week, TotalEnergies signed a deal with HD Hyundai Chemical for 200,000 tons of LNG annually starting in 2027.

Also, TotalEnergies signed a 10-year agreement to supply Air France-KLM with 1.5 million tons of sustainable aviation fuel (SAF) through 2035.

Investors can gain exposure to the stock via Advisor Managed Portfolios Miller Value Partners Appreciation ETF and Octane All-Cap Value Energy ETF ( OCTA ) .

Price Action: TTE shares are up 0.84% at $66.22 premarket at the last check Friday.

Read Next:

Shell, TotalEnergies, Equinor Complete Carbon Storage Project: Exec Says Joint Venture Plays ‘Vital’ Environmental Role

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved